Dollars for Docs

How Industry Dollars Reach Your Doctors

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

PAUL J ORCHARD
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

PAUL J ORCHARD

Listed Specialty: Pediatric Hematology-Oncology
516 DELAWARE ST SE, PWB FIFTH FLOOR, SUITE 5-100, CLINIC 5B, MINNEAPOLIS, MN, 55455-0356
Search this name in Dollars for Docs Archive →
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

PAUL ORCHARD,
Yearly Payment Breakdown:

2018 Payments At a Glance

14

payments

$45,792

payment total

3

companies paid this doctor

Payment Calendar in 2018

This doctor received a payment on days in 2018.

Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.

2018

Types of Payments in 2018

Category Payments Payment Value
Promotional Speaking/Other
 3 $21,409
Consulting
 3 $15,310
Travel and Lodging
 7 $8,960
Food and Beverage
 1 $113

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
ALDURAZYME

drug

 $21,204
NO PRODUCT DISCUSSED

drug

 $11,309
NAGLAZYME

drug

 $7,736
VIMIZIM

drug

 $7,736
MOZOBIL

drug

 $5,430
DISEASE STATE

drug

 $113
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details in 2018

When How Much Related To What For From Third Party Payee
Jul 7, 2018 $14,040 ALDURAZYME Promotional Speaking/Other SANOFI-AVENTIS U.S. LLC
Nov 13, 2018 $8,580 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Jul 7, 2018 $6,095 ALDURAZYME Travel and Lodging SANOFI-AVENTIS U.S. LLC
Jun 1, 2018 $5,430 MOZOBIL Consulting GENZYME CORPORATION
Jan 31, 2018 $4,181 VIMIZIM NAGLAZYME Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Jun 29, 2018 $3,188 VIMIZIM NAGLAZYME Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Jun 22, 2018 $1,300 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Aug 3, 2018 $724 NO PRODUCT DISCUSSED Travel and Lodging GENZYME CORPORATION
Aug 3, 2018 $705 NO PRODUCT DISCUSSED Travel and Lodging GENZYME CORPORATION
Jul 7, 2018 $560 ALDURAZYME Travel and Lodging SANOFI-AVENTIS U.S. LLC
Jul 7, 2018 $509 ALDURAZYME Travel and Lodging SANOFI-AVENTIS U.S. LLC
Feb 4, 2018 $241 VIMIZIM NAGLAZYME Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
Feb 4, 2018 $126 VIMIZIM NAGLAZYME Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
Aug 3, 2018 $113 DISEASE STATE Food and Beverage GENZYME CORPORATION
See this doctor’s Open Payments page →

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.